These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 31342628)
61. MicroRNA-194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma. Nofech-Mozes R; Khella HW; Scorilas A; Youssef L; Krylov SN; Lianidou E; Sidiropoulos KG; Gabril M; Evans A; Yousef GM Cancer Med; 2016 Apr; 5(4):656-64. PubMed ID: 26860079 [TBL] [Abstract][Full Text] [Related]
62. miR-106b-5p promotes renal cell carcinoma aggressiveness and stem-cell-like phenotype by activating Wnt/β-catenin signalling. Lu J; Wei JH; Feng ZH; Chen ZH; Wang YQ; Huang Y; Fang Y; Liang YP; Cen JJ; Pan YH; Liao B; Chen WF; Chen W; Luo JH Oncotarget; 2017 Mar; 8(13):21461-21471. PubMed ID: 28423523 [TBL] [Abstract][Full Text] [Related]
63. Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing. Jin X; Chen Y; Chen H; Fei S; Chen D; Cai X; Liu L; Lin B; Su H; Zhao L; Su M; Pan H; Shen L; Xie D; Xie C Clin Cancer Res; 2017 Sep; 23(17):5311-5319. PubMed ID: 28606918 [No Abstract] [Full Text] [Related]
64. MicroRNAs MiR-15a and MiR-26a cooperatively regulate O-GlcNAc-transferase to control proliferation in clear cell renal cell carcinoma. Kalantzakos TJ; Sullivan TB; Sebel LE; Canes D; Burks EJ; Moinzadeh A; Rieger-Christ KM Cancer Biomark; 2021; 30(3):343-351. PubMed ID: 33337348 [TBL] [Abstract][Full Text] [Related]
65. Identification of miR-20a-5p as Robust Normalizer for Urine microRNA Studies in Renal Cell Carcinoma and a Profile of Dysregulated microRNAs. Oto J; Herranz R; Plana E; Sánchez-González JV; Pérez-Ardavín J; Hervás D; Fernández-Pardo Á; Cana F; Vera-Donoso CD; Martínez-Sarmiento M; Medina P Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360679 [TBL] [Abstract][Full Text] [Related]
66. Detection of urinary miRNAs for diagnosis of clear cell renal cell carcinoma. Cochetti G; Cari L; Nocentini G; Maulà V; Suvieri C; Cagnani R; Rossi De Vermandois JA; Mearini E Sci Rep; 2020 Dec; 10(1):21290. PubMed ID: 33277569 [TBL] [Abstract][Full Text] [Related]
67. Exosome-mediated miR-9-5p promotes proliferation and migration of renal cancer cells both in vitro and in vivo by targeting SOCS4. Song W; Chen Y; Zhu G; Xie H; Yang Z; Li L Biochem Biophys Res Commun; 2020 Sep; 529(4):1216-1224. PubMed ID: 32819588 [TBL] [Abstract][Full Text] [Related]
68. Expressions of miR-96-5p, miR-29b-3p, and Their Target Gene THBS1 in Clear Cell Renal Cell Carcinoma and Sunitinib Resistance. Wu S; Wang Y Altern Ther Health Med; 2024 Jul; 30(7):268-273. PubMed ID: 37971460 [TBL] [Abstract][Full Text] [Related]
69. Down-regulation of miR-497 is associated with poor prognosis in renal cancer. Zhao X; Zhao Z; Xu W; Hou J; Du X Int J Clin Exp Pathol; 2015; 8(1):758-64. PubMed ID: 25755771 [TBL] [Abstract][Full Text] [Related]
70. The exosome encapsulated microRNAs as circulating diagnostic marker for hepatocellular carcinoma with low alpha-fetoprotein. Ghosh S; Bhowmik S; Majumdar S; Goswami A; Chakraborty J; Gupta S; Aggarwal S; Ray S; Chatterjee R; Bhattacharyya S; Dutta M; Datta S; Chowdhury A; Dhali GK; Banerjee S Int J Cancer; 2020 Nov; 147(10):2934-2947. PubMed ID: 32441313 [TBL] [Abstract][Full Text] [Related]
71. Feedback activation of GATA1/miR-885-5p/PLIN3 pathway decreases sunitinib sensitivity in clear cell renal cell carcinoma. Yao D; Xia S; Jin C; Zhao W; Lan W; Liu Z; Xiu Y Cell Cycle; 2020 Sep; 19(17):2195-2206. PubMed ID: 32783497 [TBL] [Abstract][Full Text] [Related]
72. New mechanistic insights of clear cell renal cell carcinoma from integrated miRNA and mRNA expression profiling studies. Qi Y; Wang L; Wang K; Peng Z; Ma Y; Zheng Z; Shang D; Xu W; Zheng J Biomed Pharmacother; 2019 Mar; 111():821-834. PubMed ID: 30616081 [TBL] [Abstract][Full Text] [Related]
73. microRNA-210-3p depletion by CRISPR/Cas9 promoted tumorigenesis through revival of TWIST1 in renal cell carcinoma. Yoshino H; Yonemori M; Miyamoto K; Tatarano S; Kofuji S; Nohata N; Nakagawa M; Enokida H Oncotarget; 2017 Mar; 8(13):20881-20894. PubMed ID: 28152509 [TBL] [Abstract][Full Text] [Related]
74. LINC02532 Contributes to Radiosensitivity in Clear Cell Renal Cell Carcinoma through the miR-654-5p/YY1 Axis. Zhou X; Zeng B; Li Y; Wang H; Zhang X Molecules; 2021 Nov; 26(22):. PubMed ID: 34834139 [TBL] [Abstract][Full Text] [Related]
75. LncRNA DLEU1 accelerates the malignant progression of clear cell renal cell carcinoma via regulating miRNA-194-5p. He GZ; Yu SY; Zhou QP; Chen ML; Zhang YW; Zheng Y; Zhang ZB; Han ZY; Yu J Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10691-10698. PubMed ID: 31858537 [TBL] [Abstract][Full Text] [Related]
76. miR-122 promotes metastasis of clear-cell renal cell carcinoma by downregulating Dicer. Fan Y; Ma X; Li H; Gao Y; Huang Q; Zhang Y; Bao X; Du Q; Luo G; Liu K; Meng Q; Zhao C; Zhang X Int J Cancer; 2018 Feb; 142(3):547-560. PubMed ID: 28921581 [TBL] [Abstract][Full Text] [Related]
77. CircAGAP1 promotes tumor progression by sponging miR-15-5p in clear cell renal cell carcinoma. Lv Q; Wang G; Zhang Y; Shen A; Tang J; Sun Y; Ma C; Wang P J Exp Clin Cancer Res; 2021 Feb; 40(1):76. PubMed ID: 33618745 [TBL] [Abstract][Full Text] [Related]
78. Long non-coding RNA ZFAS1 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-10a/SKA1 pathway. Dong D; Mu Z; Wei N; Sun M; Wang W; Xin N; Shao Y; Zhao C Biomed Pharmacother; 2019 Mar; 111():917-925. PubMed ID: 30841471 [TBL] [Abstract][Full Text] [Related]
79. MiR-337-3p suppresses the proliferation and metastasis of clear cell renal cell carcinoma cells via modulating Capn4. Zhuang Q; Shen J; Chen Z; Zhang M; Fan M; Xue D; Lu H; Xu R; He X; Hou J Cancer Biomark; 2018; 23(4):515-525. PubMed ID: 30452399 [TBL] [Abstract][Full Text] [Related]
80. Urinary MicroRNA-30c-5p and MicroRNA-192-5p as potential biomarkers of ischemia-reperfusion-induced kidney injury. Zou YF; Wen D; Zhao Q; Shen PY; Shi H; Zhao Q; Chen YX; Zhang W Exp Biol Med (Maywood); 2017 Mar; 242(6):657-667. PubMed ID: 28056546 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]